Various potential synthetic lethal approaches that focus on p53-mutated tumor cells include the key determinant targeting of ATR replication fork stability [111], PI3-kinase signaling cascade components [121], WEE1 protein kinase [123], and CHK1/2 DNA damage checkpoint kinase [140]. The gene discussed is CHEK1; the disease is neoplasm.